In Silico Investigations of Adaptive Therapy Using Two Cytotoxic or Two Cytostatic Drugs
Saha, D. K.; Anderson, A. R. A.; Cisneros, L.; Maley, C. C.
Show abstract
While the dose modulation (DM) protocols (DM Cocktail Tandem, DM Ping-Pong Alternate Every Cycle, DM Ping-Pong on Progression) involves adjusting drug dosages when the tumor burden changes, the fixed-dose (FD) protocols involves administering a specific, constant dosage of the drug only when the tumor is growing (Dose-Skipping) or when the absolute tumor burden is above the baseline level until it reduces to a certain percentage of the baseline (Intermittent). Moreover, two different drugs can be administered simultaneously (cocktail), or the drugs can be switched such that only one drug is applied at a given time (ping-pong), either every cycle (ping-pong alternate every cycle) or when the tumor grows (ping-pong on progression). The dose modulation protocols work well when treated with two cytotoxic drugs, however, the ping-pong protocols (DM Ping-Pong Alternate Every Cycle, DM Ping-Pong on Progression, FD Ping-Pong Intermittent) work well when treated with two cytostatic drugs. In general, adaptive therapy, using either two cytotoxic or two cytostatic drugs works best under conditions of high competition, such as high fitness cost, high replacement rates, and high turnover, although treatment using two cytostatic drugs works best under low turnover in many cases. Adaptive therapy works best when drug dosages are changed as soon as a change in tumor burden is detected, and it is best to pause treatment sooner rather than later when the tumor is shrinking. Adaptive therapy works best when an intermediate level of drug dosage is used, and both treatment with too little or too much drug leads to poor survival outcome.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Predicting drug sensitivity of cancer cells based on DNA methylation levels 93%
- Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms 91%
- Reshaping the Landscape of Locoregional Treatments for Breast Cancer Liver Metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells in the liver. 91%
Similar papers in this journal
- Chemotherapy-Induced Cachexia and Model-Informed Dosing to Preserve Lean Mass in Cancer Treatment 94%
- Quantification of long-term doxorubicin response dynamics in breast cancer cell lines to direct treatment schedules 93%
- A regularized functional regression model enabling transcriptome-wide dosage-dependent association study of cancer drug response 93%
Similar papers in this journal
- Non-parametric synergy modeling with Gaussian processes 93%
- Empirical methods for the validation of Time-To-Event mathematical models taking into account uncertainty and variability: Application to EGFR+ Lung Adenocarcinoma. 93%
- vCOMBAT: a Novel Tool to Create and Visualize a COmputational Model of Bacterial Antibiotic Target-binding 90%
Similar papers in this journal
- Inverse planning for radiofrequency ablation in cancer therapy using multiple damage models 88%
- RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancer 87%
- Strict lockdown versus flexible social distance strategy for COVID-19 disease: a cost-effectiveness analysis 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.